JPMorgan Chase & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.12B | Buy |
|
|||||
|
2025
Q1 | $1.24B | Buy |
|
|||||
|
2024
Q4 | $518M | Sell |
|
|||||
|
2024
Q3 | $559M | Sell |
|
|||||
|
2024
Q2 | $482M | Buy |
|
|||||
|
2024
Q1 | $485M | Buy |
|
|||||
|
2023
Q4 | $454M | Buy |
|
|||||
|
2023
Q3 | $409M | Buy |
|
|||||
|
2023
Q2 | $350M | Buy |
|
|||||
|
2023
Q1 | $372M | Sell |
|
|||||
|
2022
Q4 | $421M | Sell |
|
|||||
|
2022
Q3 | $310M | Sell |
|
|||||
|
2022
Q2 | $330M | Sell |
|
|||||
|
2022
Q1 | $338M | Buy |
|
|||||
|
2021
Q4 | $230M | Buy |
|
|||||
|
2021
Q3 | $166M | Sell |
|
|||||
|
2021
Q2 | $239M | Sell |
|
|||||
|
2021
Q1 | $232M | Sell |
|
|||||
|
2020
Q4 | $214M | Buy |
|
|||||
|
2020
Q3 | $172M | Sell |
|
|||||
|
2020
Q2 | $213M | Sell |
|
|||||
|
2020
Q1 | $530M | Buy |
|
|||||
|
2019
Q4 | $406M | Sell |
|
|||||
|
2019
Q3 | $442M | Sell |
|
|||||
|
2019
Q2 | $553M | Sell |
|
|||||
|
2019
Q1 | $749M | Sell |
|
|||||
|
2018
Q4 | $870M | Sell |
|
|||||
|
2018
Q3 | $1.25B | Buy |
|
|||||
|
2018
Q2 | $1.08B | Buy |
|
|||||
|
2018
Q1 | $1.1B | Buy |
|
|||||
|
2017
Q4 | $853M | Sell |
|
|||||
|
2017
Q3 | $1.05B | Sell |
|
|||||
|
2017
Q2 | $935M | Buy |
|
|||||
|
2017
Q1 | $878M | Sell |
|
|||||
|
2016
Q4 | $1.55B | Sell |
|
|||||
|
2016
Q3 | $1.93B | Sell |
|
|||||
|
2016
Q2 | $2.61B | Buy |
|
|||||
|
2016
Q1 | $2.76B | Buy |
|
|||||
|
2015
Q4 | $2.59B | Buy |
|
|||||
|
2015
Q3 | $2.36B | Sell |
|
|||||
|
2015
Q2 | $3.11B | Buy |
|
|||||
|
2015
Q1 | $1.91B | Sell |
|
|||||
|
2014
Q4 | $2.09B | Buy |
|
|||||
|
2014
Q3 | $2.33B | Buy |
|
|||||
|
2014
Q2 | $1.77B | Sell |
|
|||||
|
2014
Q1 | $1.6B | Sell |
|
|||||
|
2013
Q4 | $1.74B | Buy |
|
|||||
|
2013
Q3 | $1.32B | Buy |
|
|||||
|
2013
Q2 | $985M | Buy |
|